1Simon F,Calzia E,Radermacher P,et al.Beneficial Effects of Erythropoietin in Models of Shock and Organ Failure-Nothing Is Simple and Easy.[J] Shock,2009,31(2):220-221.
2John E Baker.Erythropoietin mimics is chemicpreconditioning[J].Vascul Pharmacol,2005,42(5-6):33-41.
3Sharples EJ,Yaqoob MM.Erythropoietin in Experimental Acute Renal Failure[J].Nephron Exp Nephrol,2006,104(3):83-88.
4Zheqing Cai,Greggl.Semenza.et al.Extra-Hematopoietic Action of Erythropoietin[J].Nephro Endocrinology,2009,16(3):25-30.
6Chul Woo Yang,Can Li,Ju Young Jung,et al.Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney[J].The FASEB Journal,2003,17(12):1754-1755.
7Abd El-Aziz M.Hussein,Ahmed A.Shokeir,Mohammed E.Sarhan,et al.Effects of combined erythropoietin and epidermal growth factor on renal ischaemia/reperfusion injury:a randomized experimental controlled study[J].BJU Int,2010,25(1):2-5.
9DW Johnson,B Pat,DA Vesey,et al.Delayed administration of darbepoetin or erythropoietin protects against ischemicacute renal injury and failure[J].Kidney Int,2006,69:1806-1813.
10Chong ZZ,Kang JQ,Maiese K.Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases[J].Circulation,2002,106:2973-2879.
